on PREDILIFE (EPA:ALPRE)
Results of the PREDILIFE General Meeting
PREDILIFE, a company specializing in AI for predicting disease risks, held its ordinary and extraordinary general meeting on June 30, 2026, in Saint Cloud. At this meeting, all resolutions proposed by the board of directors were adopted with a vote exceeding 99%.
The items voted on included the approval of the 2025 annual accounts, the decision on the allocation of profits, the renewal of authorizations for capital increases, and the appointment of a new director. Full details of the votes are available on the Predilife website.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all PREDILIFE news